OÜ RNAexact is a OÜ based in Tartu linn, registry code 14009275, status: active. Main activity: Research and experimental development on biotechnology. According to EMTA, turnover for Q2 2023 was €3 491 with employees.
Turnover
3 491 €
↑ 36.2%vs Q1 2023
State taxes
337 €
↓ 16.0%vs Q1 2023
Labour taxes
0 €
Employees
—
Q2 2023 · data from the Tax and Customs Board (EMTA)
Position in the industry Scientific research and development · EMTAK 72
Turnover · Q2 20233 491 €
above 21% of companies
industry median 15 775 € · companies in the industry: 251
Revenue · 20250 €
above 5% of companies
industry median 0 € · companies in the industry: 1 073
Taxes and turnover
Q1 2022 – Q2 2023
Turnover, € Q2 2023: 3 491 € · +36.2% vs Q1 2023 · industry median 15 775 € · above 21% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
State taxes, € Q2 2023: 337 € · −16.0% vs Q1 2023
Figures by quarter
Quarter
Turnover, €
State taxes, €
Labour taxes, €
Employees
Q2 2023
3 491
337
—
—
Q1 2023
2 563
401
—
—
Q4 2022
818
46
—
—
Q3 2022
—
—
—
—
Q2 2022
1 283
130
—
—
Q1 2022
1 365
151
—
—
Financials by year
2016 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit, € 2025: -102 € · +93.4% vs 2024 · industry median 0 € · above 31% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit margin, % 2023: -6.3 % · +13.2 pp vs the year before · industry median 16.8 % · above 23% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Assets, € 2025: 3 948 € · −2.9% vs 2024Equity, € 2025: 3 357 € · −2.9% vs 2024Employees2025: 0 · industry median 1 · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Financials by year
Year
Revenue, €
Net profit, €
Labour costs, €
Assets, €
Equity, €
Employees
2025
0
-102
0
3 948
3 357
0
2024
0
-1 539
0
4 068
3 459
0
2023
2 029
-127
0
5 499
4 998
0
2022
2 930
-569
0
6 067
5 126
0
2021
4 954
10
0
8 044
5 695
0
2020
6 487
232
0
8 129
5 684
0
2019
5 936
1 376
0
7 458
5 453
0
2018
—
—
—
—
—
0
2017
—
—
—
—
—
0
2016
—
—
—
—
—
0
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
